SG11201604755QA - Substituted dihydro-benzimidazole compounds as ror gamma modulators - Google Patents

Substituted dihydro-benzimidazole compounds as ror gamma modulators

Info

Publication number
SG11201604755QA
SG11201604755QA SG11201604755QA SG11201604755QA SG11201604755QA SG 11201604755Q A SG11201604755Q A SG 11201604755QA SG 11201604755Q A SG11201604755Q A SG 11201604755QA SG 11201604755Q A SG11201604755Q A SG 11201604755QA SG 11201604755Q A SG11201604755Q A SG 11201604755QA
Authority
SG
Singapore
Prior art keywords
benzimidazole compounds
ror gamma
substituted dihydro
gamma modulators
modulators
Prior art date
Application number
SG11201604755QA
Inventor
Sanjib Das
Abraham Thomas
Neelima Khairatkar-Joshi
Daisy Manish Shah
Malini Bajpai
Original Assignee
Glenmark Pharmaceuticals Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glenmark Pharmaceuticals Sa filed Critical Glenmark Pharmaceuticals Sa
Publication of SG11201604755QA publication Critical patent/SG11201604755QA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
SG11201604755QA 2013-10-10 2014-10-09 Substituted dihydro-benzimidazole compounds as ror gamma modulators SG11201604755QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN3207MU2013 2013-10-10
PCT/IB2014/065175 WO2015052675A1 (en) 2013-10-10 2014-10-09 Substituted dihydro-benzimidazole compounds as ror gamma modulators

Publications (1)

Publication Number Publication Date
SG11201604755QA true SG11201604755QA (en) 2016-07-28

Family

ID=52812568

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201604755QA SG11201604755QA (en) 2013-10-10 2014-10-09 Substituted dihydro-benzimidazole compounds as ror gamma modulators

Country Status (3)

Country Link
CA (1) CA2933618A1 (en)
SG (1) SG11201604755QA (en)
WO (1) WO2015052675A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104926733B (en) * 2014-03-18 2019-05-10 北京韩美药品有限公司 Compound as ROR gamma modulators
CN107721930A (en) * 2017-09-28 2018-02-23 湖南天济草堂制药股份有限公司 1 (2 fluorophenyl) 3 of substitution(3 propyl group hexyls)Carbamide compounds, pharmaceutical composition and purposes
CN112689637B (en) * 2018-09-13 2023-11-10 橘生药品工业株式会社 Imidazopyridone compounds
CA3161323A1 (en) * 2019-12-10 2021-06-17 Shanghai Zhimeng Biopharma, Inc. Compound having neuroprotective effect, preparation method therefor and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080207659A1 (en) * 2007-02-15 2008-08-28 Asit Kumar Chakraborti Inhibitors of phosphodiesterase type 4
WO2012027965A1 (en) * 2010-09-01 2012-03-08 Glaxo Group Limited Novel compounds
WO2012100734A1 (en) * 2011-01-24 2012-08-02 Glaxo Group Limited Compounds useful as retinoid-related orphan receptor gamma modulators
WO2012131501A1 (en) * 2011-03-28 2012-10-04 Glenmark Pharmaceuticals S.A. Substituted benzimidazole compounds as cot kinase inhibitors
WO2013171729A2 (en) * 2013-01-08 2013-11-21 Glenmark Pharmaceuticals S.A. Aryl and heteroaryl amide compounds as rorgamat modulator

Also Published As

Publication number Publication date
WO2015052675A1 (en) 2015-04-16
CA2933618A1 (en) 2015-04-16

Similar Documents

Publication Publication Date Title
HRP20190483T1 (en) Ror gamma (rory) modulators
IL290153A (en) Substituted tetrahydroquinolinone compounds as ror gamma modulators
IL263878B (en) Compounds as modulators of ror gamma
HK1254692A1 (en) Novel compounds as ror gamma modulators
IL244930A0 (en) Quinolinyl modulators of ror gamma t
ZA201604454B (en) Bicyclic heteroaryl indole analogues useful as ror gamma modulators
SG11201604755QA (en) Substituted dihydro-benzimidazole compounds as ror gamma modulators
IL243957A0 (en) Formulations containing gamma secretase modulators